Patents Assigned to Allergan Pharmaceuticals Holdings (Ireland) Unlimited Company
  • Patent number: 10433928
    Abstract: An improved injector needle apparatus is described with inherent properties for increasing linear flow rates when inserted into a subcutaneous port during tissue expansion thus decreasing procedure time.
    Type: Grant
    Filed: March 10, 2016
    Date of Patent: October 8, 2019
    Assignee: Allergan Pharmaceuticals Holdings (Ireland) Unlimited Company
    Inventor: Jacob G. Unger